Clinical Trial Update: RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell Carcinoma [NA]

View source ↗

Summary

This clinical trial investigating radiofrequency ablation of metastatic lesions in patients receiving antiangiogenic therapy for stage IV renal cell carcinoma h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Renal Cell Carcinoma | NA | Status: WITHDRAWN